Company Website

Contact Information:

Dan Mancuso
dmancuso@natera.com
(602) 478-3133

Jay Trushenski
jtrushenski@natera.com
(612) 718-0327

                                                                                                                                                                                                                                                                        Virtual Exhibit Hall Home



Next-Level Insights, Next-Level Care. Natera provides advanced DNA technology that enables nephrologists to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular technology, we’ve performed more than 2 million cfDNA tests and are dedicated to improving kidney care for good.

Provide insights and personalize care with genetic testing: RenasightTM is a comprehensive gene panel that analyzes over 380 genes associated with kidney disease, with greater than 99% detection rates across genes screened. Make informed, confident treatment decisions for your transplant patients: ProsperaTM uniquely assesses all types of kidney transplant rejection with great precision by leveraging expertise in cell-free DNA.

When you have access to the knowledge that these technologies provide, you’ll be better equipped to provide optimal care for the kidneys throughout the organs’ lifecycle. Discover how you can get the DNA insights you need to offer patients the treatment they need.
                               
Additional Information
Prospera - Donor Derived Cell Free DNA test for kidney rejection
Renasight - 382 Gene Panel to help diagnose CKD